Showing 1 - 14 results of 14 for search 'Bryan P. Schneider', query time: 0.07s
Refine Results
-
1
-
2
-
3
Functional microRNAs in Alzheimer’s disease and cancer: differential regulation of common mechanisms and pathways by Kelly N Holohan, Kelly N Holohan, Kelly N Holohan, Debomoy K Lahiri, Debomoy K Lahiri, Bryan P Schneider, Bryan P Schneider, Tatiana M Foroud, Andrew J Saykin, Andrew J Saykin, Andrew J Saykin
Published 2013-01-01
Article -
4
“How is it going to help?”: Exploring Black breast cancer patients’ questions about biomarker testing to predict chemotherapy-induced peripheral neuropathy by Katharine J. Head, Lisa R. Hayes, Nadia E. Miller, Safia Shakil, Casey L. Bales, Bryan P. Schneider
Published 2023-12-01
Article -
5
-
6
-
7
Altered cerebral blood flow one month after systemic chemotherapy for breast cancer: a prospective study using pulsed arterial spin labeling MRI perfusion. by Kelly N H Nudelman, Yang Wang, Brenna C McDonald, Susan K Conroy, Dori J Smith, John D West, Darren P O'Neill, Bryan P Schneider, Andrew J Saykin
Published 2014-01-01
Article -
8
Molecular and clinical effects of aromatase inhibitor therapy on skeletal muscle function in early-stage breast cancer by Tara A. Seibert, Lei Shi, Sandra Althouse, Richard Hoffman, Bryan P. Schneider, Kristen A. Russ, Cody A. Altherr, Stuart J. Warden, Theresa A. Guise, Andrew R. Coggan, Tarah J. Ballinger
Published 2024-01-01
Article -
9
-
10
Transcriptome-wide association study uncovers the role of essential genes in anthracycline-induced cardiotoxicity by Erika N. Scott, Galen E. B. Wright, Britt I. Drögemöller, Jafar S. Hasbullah, Erandika P. Gunaretnam, Fudan Miao, Amit P. Bhavsar, Fei Shen, Bryan P. Schneider, Bruce C. Carleton, Colin J. D. Ross
Published 2021-05-01
Article -
11
Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancer by Elizabeth J. Rowe, Tyler Shugg, Reynold C. Ly, Santosh Philips, Marc B. Rosenman, John T. Callaghan, John T. Callaghan, Milan Radovich, Brian R. Overholser, Brian R. Overholser, Bryan P. Schneider, James E. Tisdale, James E. Tisdale, Todd C. Skaar
Published 2022-12-01
Article -
12
Computational pharmacogenotype extraction from clinical next-generation sequencing by Tyler Shugg, Reynold C. Ly, Wilberforce Osei, Elizabeth J. Rowe, Caitlin A. Granfield, Ty C. Lynnes, Elizabeth B. Medeiros, Jennelle C. Hodge, Amy M. Breman, Bryan P. Schneider, S. Cenk Sahinalp, Ibrahim Numanagić, Benjamin A. Salisbury, Steven M. Bray, Ryan Ratcliff, Todd C. Skaar
Published 2023-07-01
Article -
13
Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers by Bradley A. Hancock, Yu-Hsiang Chen, Jeffrey P. Solzak, Mufti N. Ahmad, David C. Wedge, Dumitru Brinza, Charles Scafe, James Veitch, Rajesh Gottimukkala, Walt Short, Rutuja V. Atale, Mircea Ivan, Sunil S. Badve, Bryan P. Schneider, Xiongbin Lu, Kathy D. Miller, Milan Radovich
Published 2019-08-01
Article -
14
A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer by Jennifer R. Diamond, S. G. Eckhardt, Todd M. Pitts, Adrie van Bokhoven, Dara Aisner, Daniel L. Gustafson, Anna Capasso, Sharon Sams, Peter Kabos, Kathryn Zolman, Tiffany Colvin, Anthony D. Elias, Anna M. Storniolo, Bryan P. Schneider, Dexiang Gao, John J. Tentler, Virginia F. Borges, Kathy D. Miller
Published 2018-08-01
Article